Bhaskor Kolita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bhaskor Kolita has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Surovi Saikia
Chemical Sciences & Technology (Natural Products Chemistry) Division, CSIR North East Institute of Science & Technology, Jorhat, Assam, India
5 shared publications- Manobjyoti Bordoloi
Department of Chemistry, Assam University
4 shared publications Manobjyoti Bordoloi
Natural Products Chemistry Group, CSIR North East Institute of Science & Technology, Jorhat-785006, Assam, India
2 shared publicationsPartha P. Dutta
2 shared publicationsPartha Pratim Dutta
Natural Product Chemistry Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, India
2 shared publicationsRajeev Sarmah
Allied Health Sciences, Assam Down Town University, Panikhaiti, Guwahati, Assam, India
2 shared publications
Latest Publications
- 22 October 2026
- Published by Taylor & Francis
- p. 188-210
Fruit Waste as a Source of Biosorbent
Growing concerns about environmental pollution and the overuse of natural resources have increased interest in sustainable ways to manage waste and control pollution. One promising approach is the use of fruit waste (FW) as a biosorbent and as a feedstock for biochar production. FW including peels, rinds, and fibers from various tropical and subtropical fruits offers an eco-friendly, low-cost alternative to conventional sorbents for removing heavy metals, dyes, organic pollutants, and other toxic substances from water and soil. These materials possess high sorption capacities and are readily available, aligning with the principles of a circular economy by turning waste into a valuable resource. Through pyrolysis, FW can also be converted into biochar, a porous carbonaceous solid that enhances soil quality, reduces nutrient leaching, and supports land remediation efforts. Despite high pollutant removal efficiencies reported in laboratory studies, such as over 90% for dyes and organic contaminants, challenges remain, including variability in waste composition, pretreatment requirements, and potential environmental impact of chemical modifications. Ongoing research focuses on improving biosorbent performance through nanomaterial integration, green functionalization methods, and the development of multifunctional sorbents. Advances in process optimization and automation, such as continuous-flow systems, further improve scalability. Additionally, integrating biosorption with complementary green technologies like phytoremediation and microbial biotechnology may enhance overall remediation efficiency. As policy and market incentives increasingly promote sustainability, biosorption using FW represents a viable strategy for environmental remediation and sustainable development.
- 22 October 2026
- Published by Taylor & Francis
- p. 188-210
Fruit Waste as a Source of Biosorbent
Growing concerns about environmental pollution and the overuse of natural resources have increased interest in sustainable ways to manage waste and control pollution. One promising approach is the use of fruit waste (FW) as a biosorbent and as a feedstock for biochar production. FW including peels, rinds, and fibers from various tropical and subtropical fruits offers an eco-friendly, low-cost alternative to conventional sorbents for removing heavy metals, dyes, organic pollutants, and other toxic substances from water and soil. These materials possess high sorption capacities and are readily available, aligning with the principles of a circular economy by turning waste into a valuable resource. Through pyrolysis, FW can also be converted into biochar, a porous carbonaceous solid that enhances soil quality, reduces nutrient leaching, and supports land remediation efforts. Despite high pollutant removal efficiencies reported in laboratory studies, such as over 90% for dyes and organic contaminants, challenges remain, including variability in waste composition, pretreatment requirements, and potential environmental impact of chemical modifications. Ongoing research focuses on improving biosorbent performance through nanomaterial integration, green functionalization methods, and the development of multifunctional sorbents. Advances in process optimization and automation, such as continuous-flow systems, further improve scalability. Additionally, integrating biosorption with complementary green technologies like phytoremediation and microbial biotechnology may enhance overall remediation efficiency. As policy and market incentives increasingly promote sustainability, biosorption using FW represents a viable strategy for environmental remediation and sustainable development.
- 1 October 2018
- Published by Wiley in Drug Development Research
- Vol. 80 (1) , 106-124
Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1)
Plant‐based antiviral therapy is the current need for holistic health care management, which can be achieved through screening of phytochemicals and designing of antiviral peptides. There exist certain host's factors which are directly involved for rapid viral replication causing worldwide pandemic. A total of 177 phytochemicals from Ocimum sanctum (L.), Tinospora cordifolia (Thunb.) Miers, Cinnamomum camphora (L.) J. Presl., Allium sativum (L.), Curcuma longa (L.), and Aloe vera (L.) Burm. f. were evaluated for their affinity to all viral proteins of H1N1. Applying drug filters and keeping the threshold of such filters relative to the standards, 82 compounds were found suitable for further analysis. Consensus scoring system was used for screening top ligands from 82 compounds, which screened the top 12 compounds. Highly conserved regions (>80%) which were hydrophilic, flexible, antigenic, and also charged were screened out as potent antiviral peptides. The viral proteins were taken as the targets for the modeled peptides for protein–protein docking. Further, host‐pathogen interacting network was constructed to unveil host factors involved in viral replication, from which unique protein clusters representing their involvement in viral reproduction were selected through mapping with pathway databases. Twelve compounds and five peptides were found to be highly effective against all the proteins of H1N1. Based on the uniqueness, 13 clusters of proteins were obtained which are engaged in cellular process, namely, viral reproduction, fructose‐6‐phosphate metabolism, nitrogen compound metabolism, biosynthesis, cellular process, oligodendrocyte development, localization, multiorganism process, primary metabolism, response to unfolded protein, metabolism, and response to protein and catabolism.
- 1 October 2018
- Published by Wiley in Drug Development Research
- Vol. 80 (1) , 106-124
Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1)
Plant‐based antiviral therapy is the current need for holistic health care management, which can be achieved through screening of phytochemicals and designing of antiviral peptides. There exist certain host's factors which are directly involved for rapid viral replication causing worldwide pandemic. A total of 177 phytochemicals from Ocimum sanctum (L.), Tinospora cordifolia (Thunb.) Miers, Cinnamomum camphora (L.) J. Presl., Allium sativum (L.), Curcuma longa (L.), and Aloe vera (L.) Burm. f. were evaluated for their affinity to all viral proteins of H1N1. Applying drug filters and keeping the threshold of such filters relative to the standards, 82 compounds were found suitable for further analysis. Consensus scoring system was used for screening top ligands from 82 compounds, which screened the top 12 compounds. Highly conserved regions (>80%) which were hydrophilic, flexible, antigenic, and also charged were screened out as potent antiviral peptides. The viral proteins were taken as the targets for the modeled peptides for protein–protein docking. Further, host‐pathogen interacting network was constructed to unveil host factors involved in viral replication, from which unique protein clusters representing their involvement in viral reproduction were selected through mapping with pathway databases. Twelve compounds and five peptides were found to be highly effective against all the proteins of H1N1. Based on the uniqueness, 13 clusters of proteins were obtained which are engaged in cellular process, namely, viral reproduction, fructose‐6‐phosphate metabolism, nitrogen compound metabolism, biosynthesis, cellular process, oligodendrocyte development, localization, multiorganism process, primary metabolism, response to unfolded protein, metabolism, and response to protein and catabolism.
- 16 March 2018
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 18 (1) , 87-109
Volatile Inhibitors of Phosphatidylinositol-3-Kinase (PI3K) Pathway: Anticancer Potential of Aroma Compounds of Plant Essential Oils
Background: Cancer is a grave health problem for the world as the global cancer burden rises to 14 million new cases with 8.2 million deaths every year which is expected to rise by 70% in the next 2 decades as reported by the WHO.These steady rises in death demand for rapid developments in anti-cancer agents. Essential oils, being natural and multi-component complex systems have recently attracted a lot of attention in this search for novel anti-cancer agents. Materials and Methods: The pharmaceutical attributes of essential oil components, specifically focusing on their affinity towards COX, 5-LOX, AKT, MDM2, PDK1 and mTOR which defines the phosphatidylinositol-3- kinase (PI3K) pathway, were assessed. 123 compounds present in essential oils of different plants were analyzed for their drug like attributes which were then allowed to dock with PI3K dependent receptors crucial for the development of cancer malignancies. Among them, 21 compounds were filtered possessing high druglikeness with favourable metabolism offered by major cytochromeP450 isoforms. Finally, the best docked compounds with highest binding affinities were employed for building a ligand based pharmacophore. Being inhibitors of P-glycoproteins, these molecules also exhibited good absorption profiles and noncarcinogenic properties. Further from these 21, six compounds were evaluated against A549 lung cancer cells. Results: The pharmacophoric feature obtained can be applied for both designing and screening moieties for active inhibitors of the phosphatidylinositol-3-kinase pathway specifically from essential oil compounds and these final 21 compounds can be further promoted to studies for anti-cancer drug development. Among these, six compounds exhibited promising inhibitory results against A549 lung cancer cells. Furthermore, immunoblotting assay confirmed the efficacy of the compounds for inhibiting mTOR and AKT enzymes which are bandmasters for downstream signaling of thePI3K pathway. Conclusion: Methyl nonanoate, (R)-citronellol, cis-carveol (L-carveol), 3-methyl-Cyclohexanone, 4-carene and thujopsene were finally screened for PI3K targeted anti-cancer therapies which may find direct application as inhalers or sprays against lung cancer as these compounds are highly volatile.
- 16 March 2018
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 18 (1) , 87-109
Volatile Inhibitors of Phosphatidylinositol-3-Kinase (PI3K) Pathway: Anticancer Potential of Aroma Compounds of Plant Essential Oils
Background: Cancer is a grave health problem for the world as the global cancer burden rises to 14 million new cases with 8.2 million deaths every year which is expected to rise by 70% in the next 2 decades as reported by the WHO.These steady rises in death demand for rapid developments in anti-cancer agents. Essential oils, being natural and multi-component complex systems have recently attracted a lot of attention in this search for novel anti-cancer agents. Materials and Methods: The pharmaceutical attributes of essential oil components, specifically focusing on their affinity towards COX, 5-LOX, AKT, MDM2, PDK1 and mTOR which defines the phosphatidylinositol-3- kinase (PI3K) pathway, were assessed. 123 compounds present in essential oils of different plants were analyzed for their drug like attributes which were then allowed to dock with PI3K dependent receptors crucial for the development of cancer malignancies. Among them, 21 compounds were filtered possessing high druglikeness with favourable metabolism offered by major cytochromeP450 isoforms. Finally, the best docked compounds with highest binding affinities were employed for building a ligand based pharmacophore. Being inhibitors of P-glycoproteins, these molecules also exhibited good absorption profiles and noncarcinogenic properties. Further from these 21, six compounds were evaluated against A549 lung cancer cells. Results: The pharmacophoric feature obtained can be applied for both designing and screening moieties for active inhibitors of the phosphatidylinositol-3-kinase pathway specifically from essential oil compounds and these final 21 compounds can be further promoted to studies for anti-cancer drug development. Among these, six compounds exhibited promising inhibitory results against A549 lung cancer cells. Furthermore, immunoblotting assay confirmed the efficacy of the compounds for inhibiting mTOR and AKT enzymes which are bandmasters for downstream signaling of thePI3K pathway. Conclusion: Methyl nonanoate, (R)-citronellol, cis-carveol (L-carveol), 3-methyl-Cyclohexanone, 4-carene and thujopsene were finally screened for PI3K targeted anti-cancer therapies which may find direct application as inhalers or sprays against lung cancer as these compounds are highly volatile.
- 23 August 2016
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 121 (4) , 973-987
Structure elucidation and biological activity of antibacterial compound from Micromonospora auratinigra , a soil Actinomycetes
The aim of this study was to isolate and characterize the bioactive compound of Micromonospora auratinigra, HK-10 and its antibacterial inhibitory mechanism. An oily bioactive compound was extracted from HK-10 (GenBank accession no. JN381554) and found to have promising antibacterial activity. The compound was characterized as 2-methylheptylisonicotinate (1) by 1H, 13C NMR and mass spectroscopy. MIC of this molecule was tested by micro broth dilution method and was found to be 70, 40, 80, 60, 60, and 50 μg for Staphylococcus aureus, Bacillus subtilis, Proteus vulgaris, Echerichia coli, Pseudomonas aeruginosa and Mycobacterium abscessus respectively. The effects of compound 1 was studied on bacterial membrane structure using scanning electron microscopy. The results indicated a membrane disrupting mechanism, resulting in dysfunction of the cytoplasmic membrane structure and cell death of the pathogenic bacterial strains. Kinetics of growth of the test organisms was also analysed and indicated the 2-methylheptylisonicotinate 1 as bactericidal. Further, we have studied the binding affinity of 1 towards different membrane proteins of pathogenic bacteria by in-silico analysis. 2-methylheptylisonicotinate was isolated from Micromonospora auratinigra, a rare actinobacterial strain possessing antibacterial activity through membrane disrupting mechanism and have MICs similar to standard antibiotic neomycin sulphate. It is the first report about a strain of M. auratinigra, isolated from Indo-Burma biodiversity hotspot of North East India with new antimicrobial activities. In-silico studies have also supported these results performed on various membrane targets of pathogenic bacteria. The antibacterial potential of Micromonospora auratinigra is reported for the first time. The results indicate the possible use of 2-methylheptylisonicotinate as source of antibacterial agent against dreaded human pathogens.
- 23 August 2016
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 121 (4) , 973-987
Structure elucidation and biological activity of antibacterial compound from Micromonospora auratinigra , a soil Actinomycetes
The aim of this study was to isolate and characterize the bioactive compound of Micromonospora auratinigra, HK-10 and its antibacterial inhibitory mechanism. An oily bioactive compound was extracted from HK-10 (GenBank accession no. JN381554) and found to have promising antibacterial activity. The compound was characterized as 2-methylheptylisonicotinate (1) by 1H, 13C NMR and mass spectroscopy. MIC of this molecule was tested by micro broth dilution method and was found to be 70, 40, 80, 60, 60, and 50 μg for Staphylococcus aureus, Bacillus subtilis, Proteus vulgaris, Echerichia coli, Pseudomonas aeruginosa and Mycobacterium abscessus respectively. The effects of compound 1 was studied on bacterial membrane structure using scanning electron microscopy. The results indicated a membrane disrupting mechanism, resulting in dysfunction of the cytoplasmic membrane structure and cell death of the pathogenic bacterial strains. Kinetics of growth of the test organisms was also analysed and indicated the 2-methylheptylisonicotinate 1 as bactericidal. Further, we have studied the binding affinity of 1 towards different membrane proteins of pathogenic bacteria by in-silico analysis. 2-methylheptylisonicotinate was isolated from Micromonospora auratinigra, a rare actinobacterial strain possessing antibacterial activity through membrane disrupting mechanism and have MICs similar to standard antibiotic neomycin sulphate. It is the first report about a strain of M. auratinigra, isolated from Indo-Burma biodiversity hotspot of North East India with new antimicrobial activities. In-silico studies have also supported these results performed on various membrane targets of pathogenic bacteria. The antibacterial potential of Micromonospora auratinigra is reported for the first time. The results indicate the possible use of 2-methylheptylisonicotinate as source of antibacterial agent against dreaded human pathogens.
- Open Access
- 29 March 2014
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 9 (2) , 225-229
Arabinosyl transferase inhibitor design against Mycobacterium tuberculosis using ligand based drug design approach
Antibiotic resistance is a major challenge to combat tuberculosis. Several reports of antibiotic resistance strains of Mycobacterium tuberculosis is strongly demanding the need of new and alternative antibiotics for its inhibition. Therefore, current investigation is an attempt to screen few lead molecules for the inhibition of arbinosyl transferase enzyme of M. tuberculosis. The inhibi-tion of this enzyme is an established target of many antibiotics especially ethambutol. Herein, we have considered the structure of ethambutol as a starting point to screen active compound then ethambutol. Similar compounds were searched in chemical database and six compounds were identified and considered as selective arbinosyl transferase inhibitor based on physiochemical properties, bioactivity and ADME with least docking score. The compounds viz. ZINC00388344, ZINC003884, Chemspider2057082, ZINC-00388344, ZINC0038846, Chemspider2057082, Etha17 (analog) and Etha10 (analog) were finally screened and recommended for in vitro investigation.
- 29 March 2014
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 9 (2) , 225-229
Open AccessArabinosyl transferase inhibitor design against Mycobacterium tuberculosis using ligand based drug design approach
Antibiotic resistance is a major challenge to combat tuberculosis. Several reports of antibiotic resistance strains of Mycobacterium tuberculosis is strongly demanding the need of new and alternative antibiotics for its inhibition. Therefore, current investigation is an attempt to screen few lead molecules for the inhibition of arbinosyl transferase enzyme of M. tuberculosis. The inhibi-tion of this enzyme is an established target of many antibiotics especially ethambutol. Herein, we have considered the structure of ethambutol as a starting point to screen active compound then ethambutol. Similar compounds were searched in chemical database and six compounds were identified and considered as selective arbinosyl transferase inhibitor based on physiochemical properties, bioactivity and ADME with least docking score. The compounds viz. ZINC00388344, ZINC003884, Chemspider2057082, ZINC-00388344, ZINC0038846, Chemspider2057082, Etha17 (analog) and Etha10 (analog) were finally screened and recommended for in vitro investigation.